Nvwm, LLC Vertex Pharmaceuticals Inc Transaction History

Nvwm, LLC

$382 Million
Q3 2024

A detailed history of Nvwm, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Nvwm, LLC holds 2,407 shares of VRTX stock, worth $1.13 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

2,407

Previous 2,417 0.41%

Holding current value

$1.13 Million

Previous $1.13 Million 1.15%

% of portfolio

0.29%

Previous 0.31%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$460.0 - $505.78 $4,600 - $5,057	-10 Reduced 0.41%	2,407 $1.12 Million
Q2 2024 Aug 13, 2024	SELL	$392.81 - $485.53 $3,142 - $3,884	-8 Reduced 0.33%	2,417 $1.13 Million
Q1 2024 May 06, 2024	BUY	$407.69 - $446.08 $19,161 - $20,965	47 Added 1.98%	2,425 $1.01 Million
Q4 2023 Feb 07, 2024	SELL	$343.0 - $410.68 $24,696 - $29,568	-72 Reduced 2.94%	2,378 $967,000
Q3 2023 Oct 30, 2023	BUY	$338.18 - $362.46 $3,043 - $3,262	9 Added 0.37%	2,450 $851,000
Q2 2023 Aug 08, 2023	BUY	$314.42 - $351.91 $16,349 - $18,299	52 Added 2.18%	2,441 $859,000
Q1 2023 May 11, 2023	BUY	$283.23 - $323.1 $70,807 - $80,775	250 Added 11.69%	2,389 $752,000
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $592,380 - $666,428	2,073 Added 3140.91%	2,139 $617,000
Q3 2022 Nov 15, 2022	BUY	$273.83 - $305.53 $18,072 - $20,164	66 New	66 $19,000
Q4 2021 Feb 08, 2022	SELL	$177.01 - $223.45 $4,425 - $5,586	-25 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$181.39 - $202.99 $4,534 - $5,074	25 New	25 $5,000
Q1 2021 May 11, 2021	SELL	$207.02 - $241.31 $5,175 - $6,032	-25 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$207.01 - $276.09 $869,856 - $1.16 Million	-4,202 Reduced 99.41%	25 $5,000
Q3 2020 Dec 10, 2020	BUY	$255.65 - $303.1 $34,768 - $41,221	136 Added 3.32%	4,227 $1.15 Million
Q2 2020 Aug 11, 2020	BUY	$225.48 - $295.8 $2,705 - $3,549	12 Added 0.29%	4,091 $1.19 Million
Q1 2020 May 08, 2020	BUY	$199.77 - $247.81 $96,089 - $119,196	481 Added 13.37%	4,079 $971,000
Q4 2019 Feb 07, 2020	SELL	$166.71 - $223.91 $103,693 - $139,272	-622 Reduced 14.74%	3,598 $788,000
Q3 2019 Oct 29, 2019	BUY	$166.23 - $187.09 $165,731 - $186,528	997 Added 30.93%	4,220 $715,000
Q2 2019 Aug 07, 2019	BUY	$164.61 - $190.37 $24,033 - $27,794	146 Added 4.74%	3,223 $591,000
Q1 2019 May 10, 2019	BUY	$163.73 - $194.7 $16,372 - $19,470	100 Added 3.36%	3,077 $566,000
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $462,599 - $531,576	2,758 Added 1259.36%	2,977 $574,000
Q1 2018 May 17, 2018	BUY	$151.6 - $177.13 $11,673 - $13,639	77 Added 54.23%	219 $34,000
Q4 2017 Mar 15, 2018	BUY	$137.28 - $155.55 $19,493 - $22,088	142	142 $21,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nvwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nvwm, LLC with notifications on news.

Account